This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1987 Dec;1(4):345-8.

doi: 10.1007/BF02209074.

Correction of physiological alterations of hypertension

Affiliations

PMID: 3154670
DOI: 10.1007/BF02209074

Correction of physiological alterations of hypertension

E D Frohlich. Cardiovasc Drugs Ther. 1987 Dec.

. 1987 Dec;1(4):345-8.

doi: 10.1007/BF02209074.

Author

Affiliation

¹ Alton Ochsner Medical Foundation, New Orleans, Louisiana 70121.

PMID: 3154670
DOI: 10.1007/BF02209074

No abstract available

PubMed Disclaimer

Similar articles

Favourable haemodynamic effects of a new multifactorial antihypertensive on left ventricular dimension, wall thickness and function in hypertensive patients.
Sheiban I, Arosio E, Tonni S, Montresor G, Priante F, Lechi A. Sheiban I, et al. Eur Heart J. 1992 Jun;13 Suppl A:37-44. doi: 10.1093/eurheartj/13.suppl_a.37. Eur Heart J. 1992. PMID: 1356775 Clinical Trial. No abstract available.
Single-drug therapy and reduction of left ventricular mass in hypertension.
Gottdiener JS. Gottdiener JS. Cardiologia. 1998 Nov;43(11):1177-83. Cardiologia. 1998. PMID: 9922583 Review.
[Isolated systolic arterial hypertension in elderly and senile patients].
Kipshidze NN, Zubiashvili TG. Kipshidze NN, et al. Adv Gerontol. 2006;18:66-70. Adv Gerontol. 2006. PMID: 16676800 Russian.
Effect of antihypertensive treatment with nitrendipine on left ventricular mass and diastolic filling in patients with mild to moderate hypertension.
Modena MG, Mattioli AV, Parato VM, Mattioli G. Modena MG, et al. J Cardiovasc Pharmacol. 1992 Jan;19(1):148-53. doi: 10.1097/00005344-199201000-00021. J Cardiovasc Pharmacol. 1992. PMID: 1375682
Left ventricular function and regression of left ventricular hypertrophy in essential hypertension.
Clement DL, De Buyzere M, Duprez D. Clement DL, et al. Am J Hypertens. 1993 Mar;6(3 Pt 2):14S-19S. doi: 10.1093/ajh/6.3.14s. Am J Hypertens. 1993. PMID: 8466720 Review.

See all similar articles

Cited by

Immediate and prolonged hemodynamic effects of TA-3090 on spontaneously hypertensive (SHR) and normal Wistar-Kyoto (WKY) rats.
Isshiki T, Pegram BL, Frohlich ED. Isshiki T, et al. Cardiovasc Drugs Ther. 1988 Nov;2(4):539-47. doi: 10.1007/BF00051194. Cardiovasc Drugs Ther. 1988. PMID: 3154632
Choosing the correct drug for the individual hypertensive patient.
Opie LH. Opie LH. Drugs. 1992;44 Suppl 1:147-55. doi: 10.2165/00003495-199200441-00028. Drugs. 1992. PMID: 1283579 Review.
Systolic hypertension in the elderly.
Rutan GH. Rutan GH. Cardiovasc Drugs Ther. 1991 Jan;4 Suppl 6:1203-8. doi: 10.1007/BF00114220. Cardiovasc Drugs Ther. 1991. PMID: 2009243 Review.
Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.
Opie LH. Opie LH. Cardiovasc Drugs Ther. 1988 Mar;1(6):625-56. doi: 10.1007/BF02125750. Cardiovasc Drugs Ther. 1988. PMID: 3154329 Review.

References

1. Circulation. 1979 May;59(5):1056-62 - PubMed
1. Fed Proc. 1983 Jul;42(10):2709-15 - PubMed
1. Circulation. 1987 May;75(5):1030-6 - PubMed
1. N Engl J Med. 1972 Apr 20;286(16):861-6 - PubMed
1. Circ Res. 1983 Feb;52(2 Pt 2):I3-16 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information